B-cell epitopes of the envelope glycoprotein of caprine arthritis–encephalitis virus and antibody response in infected goats Free

Abstract

Goats infected with caprine arthritis–encephalitis virus (CAEV) develop high titres of antibodies to Env. Not only is no consistent neutralizing response found but anti-Env antibodies have even been associated with disease in infected goats. To identify the continuous antigenic determinants involved in this atypical anti-Env response, we mapped CAEV-CO Env by screening an epitope expression library with infected goat sera. In addition to the four previously described epitopes, seven novel antigenic sites were identified, of which five were located on the surface (SU) and two in the transmembrane (TM) subunits of Env. The SU antibody-binding domains located in the variable regions of the C-terminal part of the molecule (SU3 to SU5) showed the strongest reactivity and induced a rapid seroconversion in six experimentally infected goats. However, the response to these immunodominant epitopes did not appear to be associated with any neutralizing activity. The pattern of serum reactivity of naturally infected goats with these epitopes was restricted, suggesting a type-specific reaction. Interestingly, the reactivity of peptides representing SU5 sequences derived from CAEV field isolates varied with the geographical and/or breeding origin of the animals. This suggests that peptides corresponding to the immunodominant SU epitopes may well be useful in the serotyping of CAEV isolates. Furthermore, the identification of the CAEV Env epitopes will permit us to functionally dissect the antibody response and to address the role of anti-Env antibodies either in the protection from or in the pathogenesis of CAEV infection.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-81-12-2929
2000-12-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jgv/81/12/0812929a.html?itemId=/content/journal/jgv/10.1099/0022-1317-81-12-2929&mimeType=html&fmt=ahah

References

  1. Baillou A., Brand D., Denis F., M’Boup S., Chout R., Goudeau A., Barin F. 1993; High antigenic cross-reactivity of the V3 consensus sequences of HIV-1 gp120. AIDS Research and Human Retroviruses 9:1209–1215
    [Google Scholar]
  2. Barin F., Lahbabi Y., Buzelay L., Lejeune B., Baillou-Beaufils A., Denis F., Mathiot C., M’Boup S., Vithayasai V., Dietrich U., Goudeau A. 1996; Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping. AIDS Research and Human Retroviruses 12:1279–1289
    [Google Scholar]
  3. Bertoni G., Zahno M.-L., Zanoni R., Vogt H.-R., Peterhans E., Ruff G., Cheevers W. P., Sonigo P., Pancino G. 1994; Antibody reactivity to the immunodominant epitopes of the caprine arthritis–encephalitis virus gp38 transmembrane protein associates with the development of arthritis. Journal of Virology 68:7139–7147
    [Google Scholar]
  4. Cheevers W. P., McGuire T. C., Norton L. K., Cordery-Cotter R., Knowles D. P. 1993; Failure of neutralising antibody to regulate CAE lentivirus expression in vivo. Virology 196:835–839
    [Google Scholar]
  5. Cheevers W. P., Knowles D. P., McGuire T. C., Baszler T. V., Hullinger G. A. 1994; Caprine arthritis–encephalitis lentivirus (CAEV) challenge of goats immunized with recombinant vaccinia virus expressing CAEV surface and transmembrane envelope glycoproteins. Veterinary Immunology and Immunopathology 42:237–251
    [Google Scholar]
  6. Domingo E., Díez J., Martínez M. A., Hernández J., Holguín A., Borrego B., Mateu M. G. 1993; New observations on antigenic diversification of RNA viruses. Antigenic variation is not dependent on immune selection. Journal of General Virology 74:2039–2045
    [Google Scholar]
  7. Ellis T. M., Wilcox G. E., Robinson W. F. 1987; Antigenic variation of caprine arthritis–encephalitis virus during persistent infection of goats. Journal of General Virology 68:3145–3152
    [Google Scholar]
  8. Goudsmit J., Debouck C., Meloen R. H., Smit L., Bakker M., Asher D. M., Wolff A. V., Gibbs C. J., Gajdusek D. C. 1988; HIV type 1 neutralization epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees. Proceedings of the National Academy of Sciences, USA 85:4478–4482
    [Google Scholar]
  9. Goudsmit J., Back N. K., Nara P. L. 1991; Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. FASEB Journal 5:2427–2436
    [Google Scholar]
  10. Grund C. H., Lechman E. R., Pezzuolo N. A., Issel C. J., Montelaro R. C. 1996; Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies. Journal of General Virology 77:435–442
    [Google Scholar]
  11. Javaherian K., Langlois A. J., McDanal C., Ross K. L., Eckler L. I., Jellis C. L., Profy A. T., Rusche J. R., Bolognesi D. P., Putney S. D., Matthews T. J. 1989; Principal neutralising domain of the human immunodeficiency virus type 1 envelope protein. Proceedings of the National Academy of Sciences, USA 86:6768–6772
    [Google Scholar]
  12. Knowles D. P., Cheevers W. P., McGuire T. C., Stem T. A., Gorham J. R. 1990; Severity of arthritis is predicted by antibody response to Gp135 in chronic infection with caprine arthritis–encephalitis virus. Journal of Virology 64:2396–2398
    [Google Scholar]
  13. Knowles D. P., Cheevers W. P., McGuire T. C., Brassfield A. L., Harwood W. G., Stem T. A. 1991; Structure and genetic variability of envelope glycoproteins of two antigenic variants of caprine arthritis–encephalitis lentivirus. Journal of Virology 65:5744–5750
    [Google Scholar]
  14. Leroux C., Chastang J., Greenland T., Mornex J. F. 1997; Genomic heterogeneity of small ruminant lentiviruses: existence of heterogeneous populations in sheep and of the same lentiviral genotypes in sheep and goats. Archives of Virology 142:1125–1137
    [Google Scholar]
  15. Lichtensteiger C. A., Knowles D. P. Jr, McGuire T. C., Cheevers W. P. 1991; Recombinant gp135 envelope glycoproteins of caprine arthritis–encephalitis lentivirus variants inhibit homologous and heterologous variant-specific neutralising antibodies. Virology 185:2–9
    [Google Scholar]
  16. Lombardi S., Garzelli C., La Rosa C., Zaccaro L., Specter S., Malvaldi G., Tozzini F., Esposito F., Bendinelli M. 1993; Identification of a linear neutralization site within the third variable region of the feline immunodeficiency virus envelope. Journal of Virology 67:4742–4749
    [Google Scholar]
  17. McGuire T. C., Norton L. K., O’Rourke K. I., Cheevers W. P. 1988; Antigenic variation of neutralization-sensitive epitopes of caprine arthritis–encephalitis lentivirus during persistent arthritis. Journal of Virology 62:3488–3492
    [Google Scholar]
  18. McGuire T. C., Knowles D. P. Jr, Davis W. C., Brassfield A. L., Stem T. A., Cheevers W. P. 1992; Transmembrane protein oligomers of caprine arthritis–encephalitis lentivirus are immunodominant in goats with progressive arthritis. Journal of Virology 66:3247–3250
    [Google Scholar]
  19. Mascola J. R., Mathieson B. J., Zack P. M., Walker M. C., Halstead S. B., Burke D. S. 1993; Summary report: workshop on the potential risks of antibody-dependent enhancement in human HIV vaccine trials. AIDS Research and Human Retroviruses 9:1175–1184
    [Google Scholar]
  20. Muster T., Steindl F., Purtscher M., Trkola A., Klima A., Himmler G., Rüker F., Katinger H. 1993; A conserved neutralising epitope on gp41 of human immunodeficiency virus type 1. Journal of Virology 67:6642–6647
    [Google Scholar]
  21. Narayan O., Sheffer D., Griffin D. E., Clements J., Hess J. 1984; Lack of neutralising antibodies to caprine arthritis–encephalitis lentivirus can be overcome by immunization with inactivated mycobacterium tuberculosis. Journal of Virology 49:349–355
    [Google Scholar]
  22. Pancino G., Chappey C., Saurin W., Sonigo P. 1993; B epitopes and selection pressures in feline immunodeficiency virus envelope glycoproteins. Journal of Virology 67:664–672
    [Google Scholar]
  23. Pancino G., Ellerbrok H., Sitbon M., Sonigo P. 1994; Conserved framework of envelope glycoproteins among lentiviruses. Current Topics in Microbiology and Immunology 188:77–105
    [Google Scholar]
  24. Plantier J. C., Damond F., Lasky M., Sankale J. L., Apetrei C., Peeters M., Buzelay L., M’Boup S., Kanki P., Delaporte E., Simon F., Barin F. 1999; V3 serotyping of HIV-1 infection: correlation with genotyping and limitations. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 20:432–441
    [Google Scholar]
  25. Pyper J. M., Clements J. E., Gonda M. A., Narayan O. 1986; Sequence homology between cloned caprine arthritis encephalitis virus and visna virus, two neurotropic lentiviruses. Journal of Virology 58:665–700
    [Google Scholar]
  26. Richardson J., Fossati I., Moraillon A., Castelot S., Sonigo P., Pancino G. 1996; Neutralization sensitivity and accessibility of continuous B cell epitopes of the feline immunodeficiency virus envelope. Journal of General Virology 77:759–771
    [Google Scholar]
  27. Richardson J., Moraillon A., Crespeau F., Baud S., Sonigo P., Pancino G. 1998; Delayed infection after immunization with a peptide from the transmembrane glycoprotein of the feline immunodeficiency virus. Journal of Virology 72:2406–2415
    [Google Scholar]
  28. Robinson W. E., Kawamura T., Lake D., Masuho Y., Mitchell W. M., Hersh E. M. 1990; Antibodies to the primary immunodominant domain of human immunodeficiency virus type 1 (HIV-1) glycoprotein 41 enhance HIV-1 infection in vitro. Journal of Virology 64:5301–5305
    [Google Scholar]
  29. Robinson W. E., Gorny M. K., Xy J. I., Mitchell W. M., Zolla-Pazner S. 1991; Two immunodominant domains of gp41 bind antibodies which enhance human immunodeficiency virus type 1 infection in vitro. Journal of Virology 65:4169–4176
    [Google Scholar]
  30. Ruano G., Pagliaro E. M., Schwartz T. R., Lamy K., Messina D., Gaensslen R. E., Lee H. C. 1992; Heat-soaked PCR: an efficient method for DNA amplification with applications to forensic analysis. BioTechniques 13:266–274
    [Google Scholar]
  31. Rusche J. R., Javaherian K., McDonald C., Petro J., Lynn D. L., Grimaila R., Langlois A., Gallo R. C., Arthur L. O., Fischinger P. J., Bolognesi D., Putney S. D., Matthews T. J. 1988; Antibodies that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proceedings of the National Academy of Sciences, USA 85:3198–3202
    [Google Scholar]
  32. Saltarelli M., Querat G., Konings D. A. M., Vigne R., Clements J. E. 1990; Nucleotide sequence and transcriptional analysis of molecular clones of CAEV which generate infectious virus. Virology 179:347–364
    [Google Scholar]
  33. Salzwedel K., West J. T., Hunter E. 1999; A conserved tryptophan-rich motif in the membrane-proximal region of the human immunodeficiency virus type 1 gp41 ectodomain is important for Env-mediated fusion and virus infectivity. Journal of Virology 73:2469–2480
    [Google Scholar]
  34. Sambrook J., Fritsch E. F., Maniatis T. 1989 Molecular Cloning: A Laboratory Manual, 2nd edn. Cold Spring Harbour, NY: Cold Spring Harbour Laboratory;
  35. Siebelink K. H. J., Tijhaar E., Huisman R. C., Huisman W., De Ronde A., Darby I. H., Francis M. J., Rimmelzwaan G. F., Osterhaus A. D. M. E. 1995; Enhancement of feline immunodeficiency virus infection after immunization with envelope glycoprotein subunit vaccines. Journal of Virology 69:3704–3711
    [Google Scholar]
  36. Skraban R., Matthiasdottir S., Torsteinsdottir S., Agnarsdottir G., Gudmundsson B., Georgsson G., Meloen R. H., Andresson O. S., Staskus K. A., Thormar H., Andresdottir V. 1999; Naturally occurring mutations within 39 amino acids in the envelope glycoprotein of maedi–visna virus alter the neutralization phenotype. Journal of Virology 73:8064–8072
    [Google Scholar]
  37. Turelli P., Guiguen F., Mornex J. F., Vigne R., Querat G. 1997; dUTPase-minus caprine arthritis–encephalitis virus is attenuated for pathogenesis and accumulates G-to-A substitutions. Journal of Virology 71:4522–4530
    [Google Scholar]
  38. Valas S., Benoit C., Guionaud C., Perrin G., Mamoun R. Z. 1997; North American and French caprine arthritis–encephalitis viruses emerge from ovine maedi–visna viruses. Virology 237:307–318
    [Google Scholar]
  39. Valas S., Benoit C., Baudry G., Perrin G., Mamoun R. Z. 2000; Variability and immunogenicity of caprine arthritis–encephalitis virus surface glycoprotein. Journal of Virology 74:6178–6185
    [Google Scholar]
  40. Wain-Hobson S., Sonigo P., Guyader M., Gazit A., Henry M. 1995; Erratic G→A hypermutation within a complete caprine arthritis–encephalitis virus (CAEV) provirus. Virology 209:297–303
    [Google Scholar]
  41. Wang S. Z. S., Rushlow K. E., Issel C. J., Cook R. F., Cook S. J., Raabe M. L., Chong Y.-H., Costa L., Montelaro R. C. 1994; Enhancement of EIAV replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 199:247–251
    [Google Scholar]
  42. Zanoni R. G. 1998; Phylogenetic analysis of small ruminant lentiviruses. Journal of General Virology 79:1951–1961
    [Google Scholar]
  43. Zanoni R., Krieg A., Peterhans E. 1989; Detection of antibodies to caprine arthritis–encephalitis virus by protein G enzyme-linked immunosorbent assay and immunoblotting. Journal of Clinical Microbiology 27:580–582
    [Google Scholar]
  44. Zheng Y. H., Sentsui H., Nakaya T., Kono Y., Ikuta K. 1997; In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: insertions/duplications at the principal neutralising domain. Journal of Virology 71:5031–5039
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-81-12-2929
Loading
/content/journal/jgv/10.1099/0022-1317-81-12-2929
Loading

Data & Media loading...

Most cited Most Cited RSS feed